Quick Takeaways
- Nancy Lurker has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $9,164,086.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Nancy Lurker and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| EYPT | EyePoint, Inc. | Director | $7,696,047 | -$150,942 | -1.9% | 06 Jan 2026 |
| ALKS | Alkermes plc. | Director | $865,034 | 31 May 2025 | ||
| COLL | COLLEGIUM PHARMACEUTICAL, INC | Director | $603,005 | 15 May 2025 | ||
| AQST | Aquestive Therapeutics, Inc. | Director | 15 Jun 2021 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|